AMSC vs JAZZ · P/E 14, rev $299.2M vs P/E 1988, rev $2.28B
American Superconductor Corporation (AMSC) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
American Superconductor Corporation (AMSC) is a specialty industrial machinery company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported AMSC revenue for 2026-03-31 was $299.2M. Net income was $133.8M. Revenue was up 34.3% from 2025-03-31 to 2026-03-31. AMSC currently screens at market cap $2.02B and trailing P/E 13.9.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
AMSC currently screens at market cap $2.02B and trailing P/E 13.9. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the AMSC and JAZZ stock pages for the full models.
Not investment advice.